Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Radiographic Axial Spondyloarthritis: early-phase trial registry

1 of 1 indexed Radiographic Axial Spondyloarthritis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Radiographic Axial Spondyloarthritis: 1 US clinical trial tracked, 1 recruiting.

Radiographic Axial Spondyloarthritis is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Merck Sharp & Dohme, running 1 of these trials.

Enrollment posture brief

Registry condition radiographic-axial-spondyloarthritis

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Radiographic Axial Spond (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Radiographic Axial Spondyloarthritis

Radiographic Axial Spondyloarthritis lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Radiographic Axial Spondyloarthritis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Radiographic Axial Spondyloarthritis is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Radiographic Axial Spondyloarthritis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Tulisokibart Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Radiographic Axial Spondyloarthritis trials. A trial with sites in several states counts in each.

New Mexico 1 trials
Nebraska 1 trials
Missouri 1 trials
Maryland 1 trials
Illinois 1 trials
Florida 1 trials
California 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Radiographic Axial Spondyloarthritis page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Radiographic Axial Spondyloarthritis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Merck Sharp & Dohme sponsors the most Radiographic Axial Spondyloarthritis trials on record, review their full trial history before evaluating a specific study. See Merck Sharp & Dohme's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Radiographic Axial Spondyloarthritis condition card totals 1 registered trials; most-linked intervention Tulisokibart; top US site state New Mexico. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.